Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Gene Therapy: the Search for the Safe and Gentle Method

09.11.2004


Scientists from three countries study innovative DNA transport element



Treating genetic diseases by introducing functional genes into the human organism: researchers from three European countries are aiming for a breakthrough in this process, known as gene therapy, using a new methodology. The network of scientists, including the German Research Centre for Biotechnology in Braunschweig (GBF), is working to further develop a certain type of DNA element, called an episome, for this purpose. The European Union is contributing financial support for the “Epi-Vector-Programme.”

During the 1990s great promise for gene therapy emerged for the first time. At this time, bio-scientists and others from the medical profession first attempted to treat people with hereditary defects by implanting a functional version of a damaged gene into the patient’s body. The initial high hopes for this process were cruelly disappointed when several of the patients contracted cancer and died.


Professor Jürgen Bode, the work group leader at GBF, is convinced that the cause of these deaths can be found in the vectors used at the time; i.e the transport elements by which the DNA was injected into a patient’s cells. “Certain viruses that were rendered harmless were used,” notes Prof. Bode, “into whose genetic substance the desired gene was integrated.” “This,” Bode explains, “was essentially a sensible approach because viruses inject their own DNA into the cells they attack; in fact, they do this at those points where it is most convenient for their own survival. Then, they let themselves be reproduced by our own cells.” The downside is that unfortunately we have no control over the location where this occurs on our chromosomes, says Bode. If a virus invades a key genetic region of a cell it can severely inhibit the functions of genetic information. In the worst case scenario, this can lead to the breakdown and loss of genes which, in turn, can result in cancer.

The GBF and the rest of the research consortium are focusing on a new type of vector called an episome. Episomes are DNA elements that do not combine themselves in the genetic substance of the host DNA. Instead, they become anchored in a reversible manner only to certain support molecules in the nucleus of the cell – the same molecules used for stabilisation by human DNA. The necessary “DNA anchors” were identified during the Human Genome Project. “Now it is possible,” says Prof. Bode, “to head straight for the stabilisation of cell nucleus molecules.” The episomes constructed are independent DNA ring molecules which have attached themselves to a chromosome in the host cell. Their information is jointly read with that of the chromosomes and together they multiply with the chromosomes every time cell division occurs.

Researchers in the Epi-Vector-Project now want to find out if episomes are suitable for a gentler form of gene therapy. Professor Bode warns however that quick successes are not likely. “Even if this method functions, considerable groundwork would still be required before the process could be applied in the medical field.”

More about the Epi-Vector-Programme

Participants in the EU-supported research programme “Episomal Vectors for Human Gene Therapy” include seven scientific institutes from Germany, England and the Netherlands. The German project partners are the universities of Witten and Hamburg, and the GBF in Braunschweig. Coordinator of the project is the molecular biologist, Dr. Dean Jackson, in Manchester/UK.

Manfred Braun | alfa
Further information:
http://www.gbf.de

More articles from Life Sciences:

nachricht 'Y' a protein unicorn might matter in glaucoma
23.10.2017 | Georgia Institute of Technology

nachricht Microfluidics probe 'cholesterol' of the oil industry
23.10.2017 | Rice University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Salmonella as a tumour medication

HZI researchers developed a bacterial strain that can be used in cancer therapy

Salmonellae are dangerous pathogens that enter the body via contaminated food and can cause severe infections. But these bacteria are also known to target...

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

3rd Symposium on Driving Simulation

23.10.2017 | Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

 
Latest News

Microfluidics probe 'cholesterol' of the oil industry

23.10.2017 | Life Sciences

Gamma rays will reach beyond the limits of light

23.10.2017 | Physics and Astronomy

The end of pneumonia? New vaccine offers hope

23.10.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>